The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Chondros Dimitrios since year 2005.
The trader's CIK number is 1739693.
At the time of the last reporting, Chondros Dimitrios was the SVP, Chief Medical Officer of Halozyme Therapeutics, Inc. .
(stock ticker symbol HALO).
See this page for all insider trading activities at Halozyme Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-08-03||HALO||Halozyme Therapeutics, Inc.||Sale||1,328||16.70||22,177|
|2019-06-01||HALO||Halozyme Therapeutics, Inc.||Option Ex||2,043||.00||0|
|2019-02-22||HALO||Halozyme Therapeutics, Inc.||Option Ex||3,884||.00||0|
|2019-02-14||HALO||Halozyme Therapeutics, Inc.||Option Ex||6,790||.00||0|
|2018-06-01||HALO||Halozyme Therapeutics, Inc.||Option Ex||2,043||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chondros Dimitrios (SVP, Chief Medical Officer of Halozyme Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.